Nosebleed breakthrough? new block may beat painful packing
NCT ID NCT07421622
First seen Feb 28, 2026 · Last updated Jun 21, 2026 · Updated 20 times
Summary
This pilot study will compare two methods for stopping nosebleeds in 40 adults: standard nasal packing and a greater palatine foramen block (an injection of numbing medicine). The main goal is to see which causes less pain and which controls bleeding better. Results will be measured 24 hours after treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GREATER PALATINE FORAMEN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
2% lidocaine with adrenaline (local anesthetic)
What this could lead to
If GPFB works better, it could offer a less painful way to stop nosebleeds in the emergency room.
What could go wrong
This is a very small pilot study (40 people) that hasn't started yet. The block may not control bleeding as well as packing, and there are risks like allergic reaction or nerve injury.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.